Clene Inc. (CLNN) DCF Valuation

Valoración de DCF de Clene Inc. (CLNN)

US | Healthcare | Biotechnology | NASDAQ
Clene Inc. (CLNN) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Clene Inc. (CLNN) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore su estrategia de inversión con la calculadora DCF de Clene Inc. (CLNN)! Utilice datos financieros de cleno real, ajuste las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estas modificaciones influyen en el valor intrínseco de Clene Inc. (CLNN).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .2 .7 .5 .7 .8 1.0 1.3 1.6 2.1
Revenue Growth, % 0 0 250.97 -34.58 38.27 25.92 25.92 25.92 25.92 25.92
EBITDA -15.2 -16.9 -8.2 -25.2 -43.2 -.5 -.6 -.8 -1.0 -1.2
EBITDA, % 100 -8214.08 -1136.38 -5330.66 -6611.77 -60 -60 -60 -60 -60
Depreciation .9 1.0 1.1 1.4 1.7 .8 1.0 1.3 1.6 2.1
Depreciation, % 100 485.44 149.65 297.67 260.7 100 100 100 100 100
EBIT -16.1 -17.9 -9.3 -26.6 -44.9 -.5 -.6 -.8 -1.0 -1.2
EBIT, % 100 -8699.51 -1286.03 -5628.33 -6872.48 -60 -60 -60 -60 -60
Total Cash 8.8 59.3 50.3 23.3 35.0 .8 1.0 1.3 1.6 2.1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 2.2 1.6 .2 1.3
Account Receivables, % 100 1052.91 223.1 39.96 204.59
Inventories .0 .2 .0 .0 .0 .4 .4 .6 .7 .9
Inventories, % 100 92.72 5.67 9.09 5.66 42.63 42.63 42.63 42.63 42.63
Accounts Payable .9 1.1 1.9 3.0 1.5 .8 1.0 1.3 1.6 2.1
Accounts Payable, % 100 545.63 265.98 637.21 229.97 100 100 100 100 100
Capital Expenditure -.3 -.4 -1.3 -5.2 -.3 -.6 -.7 -.9 -1.2 -1.5
Capital Expenditure, % 100 -187.86 -184.23 -1094.93 -50.46 -70.09 -70.09 -70.09 -70.09 -70.09
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -16.2 -18.3 -8.9 -13.6 -44.9 -.4 -.6 -.7 -.9 -1.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -14.7 -19.8 -7.7 -14.9 -46.2 -.6 -.3 -.4 -.5 -.6
WACC, % 10.69 10.69 10.36 6.87 10.69 9.86 9.86 9.86 9.86 9.86
PV UFCF
SUM PV UFCF -1.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1
Terminal Value -8
Present Terminal Value -5
Enterprise Value -7
Net Debt 3
Equity Value -10
Diluted Shares Outstanding, MM 5
Equity Value Per Share -1.94

What You Will Receive

  • Pre-Filled Financial Model: Clene Inc.’s actual data allows for accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates provide immediate feedback as you adjust parameters.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.

Key Features

  • Comprehensive Clene Financials: Gain access to precise pre-loaded historical data and future projections for Clene Inc. (CLNN).
  • Adjustable Forecast Parameters: Modify highlighted cells such as WACC, growth rates, and margins to tailor your analysis.
  • Real-Time Calculations: Benefit from automatic updates to DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: Utilize user-friendly charts and summaries to clearly present your valuation outcomes.
  • Designed for All Skill Levels: An intuitive framework suitable for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Clene Inc. (CLNN) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Clene Inc.'s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator?

  • Accurate Data: Real Clene Inc. (CLNN) financials ensure reliable valuation results.
  • Customizable: Adjust key parameters like growth rates, WACC, and tax rates to match your projections.
  • Time-Saving: Pre-built calculations eliminate the need to start from scratch.
  • Professional-Grade Tool: Designed for investors, analysts, and consultants.
  • User-Friendly: Intuitive layout and step-by-step instructions make it easy for all users.

Who Should Use Clene Inc. (CLNN)?

  • Healthcare Students: Explore innovative drug development processes and apply your knowledge to real-world scenarios.
  • Researchers: Utilize cutting-edge data in studies related to neurodegenerative diseases.
  • Investors: Evaluate your investment strategies and analyze the potential of Clene Inc. (CLNN) in the biotech sector.
  • Pharmaceutical Analysts: Enhance your analysis with a comprehensive understanding of Clene's clinical trial outcomes.
  • Entrepreneurs: Discover how emerging biotech companies like Clene Inc. (CLNN) navigate the market landscape.

What the Template Contains

  • Pre-Filled DCF Model: Clene Inc.’s (CLNN) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Clene Inc.’s (CLNN) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.